Cyclooxygénase (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Cyclooxygénase" in French language version.

refsWebsite

Global rank French rank

4^th place

12^th place

2^nd place

3^rd place

234^th place

147^th place

18^th place

118^th place

149^th place

80^th place

2,854^th place

313^th place

57^th place

4^th place

doi.org

(en) Daniel Picot, Patrick J. Loll et R. Michael Garavito, « The X-ray crystal structure of the membrane protein prostaglandin H₂ synthase-1 », Nature, vol. 367, n^o 6460,‎ 1994, p. 243-249 (PMID 8121489, DOI 10.1038/367243a0, lire en ligne)
(en) Ravi G. Kurumbail, Anna M. Stevens, James K. Gierse, Joseph J. McDonald, Roderick A. Stegeman, Jina Y. Pak, Daniel Gildehaus, Julie M. iyashiro, Thomas D. Penning, Karen Seibert, Peter C. Isakson et William C. Stallings, « Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents », Nature, vol. 384, n^o 6610,‎ 26 décembre 1996, p. 644-648 (PMID 8967954, DOI 10.1038/384644a0, Bibcode 1996Natur.384..644K, lire en ligne)
Nabil Foudi, Liliane Louedec, Thierry Cachina et Charles Brink, « Selective cyclooxygenase-2 inhibition directly increases human vascular reactivity to norepinephrine during acute inflammation », Cardiovascular Research, vol. 81, n^o 2,‎ 1^er février 2009, p. 269–277 (ISSN 1755-3245, PMID 18952694, DOI 10.1093/cvr/cvn287, lire en ligne, consulté le 11 février 2017)

(en) Ravi G. Kurumbail, Anna M. Stevens, James K. Gierse, Joseph J. McDonald, Roderick A. Stegeman, Jina Y. Pak, Daniel Gildehaus, Julie M. iyashiro, Thomas D. Penning, Karen Seibert, Peter C. Isakson et William C. Stallings, « Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents », Nature, vol. 384, n^o 6610,‎ 26 décembre 1996, p. 644-648 (PMID 8967954, DOI 10.1038/384644a0, Bibcode 1996Natur.384..644K, lire en ligne)

Nabil Foudi, Liliane Louedec, Thierry Cachina et Charles Brink, « Selective cyclooxygenase-2 inhibition directly increases human vascular reactivity to norepinephrine during acute inflammation », Cardiovascular Research, vol. 81, n^o 2,‎ 1^er février 2009, p. 269–277 (ISSN 1755-3245, PMID 18952694, DOI 10.1093/cvr/cvn287, lire en ligne, consulté le 11 février 2017)

(en) Daniel Picot, Patrick J. Loll et R. Michael Garavito, « The X-ray crystal structure of the membrane protein prostaglandin H₂ synthase-1 », Nature, vol. 367, n^o 6460,‎ 1994, p. 243-249 (PMID 8121489, DOI 10.1038/367243a0, lire en ligne)
(en) Ravi G. Kurumbail, Anna M. Stevens, James K. Gierse, Joseph J. McDonald, Roderick A. Stegeman, Jina Y. Pak, Daniel Gildehaus, Julie M. iyashiro, Thomas D. Penning, Karen Seibert, Peter C. Isakson et William C. Stallings, « Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents », Nature, vol. 384, n^o 6610,‎ 26 décembre 1996, p. 644-648 (PMID 8967954, DOI 10.1038/384644a0, Bibcode 1996Natur.384..644K, lire en ligne)

(en) Daniel Picot, Patrick J. Loll et R. Michael Garavito, « The X-ray crystal structure of the membrane protein prostaglandin H₂ synthase-1 », Nature, vol. 367, n^o 6460,‎ 1994, p. 243-249 (PMID 8121489, DOI 10.1038/367243a0, lire en ligne)
(en) Ravi G. Kurumbail, Anna M. Stevens, James K. Gierse, Joseph J. McDonald, Roderick A. Stegeman, Jina Y. Pak, Daniel Gildehaus, Julie M. iyashiro, Thomas D. Penning, Karen Seibert, Peter C. Isakson et William C. Stallings, « Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents », Nature, vol. 384, n^o 6610,‎ 26 décembre 1996, p. 644-648 (PMID 8967954, DOI 10.1038/384644a0, Bibcode 1996Natur.384..644K, lire en ligne)
Nabil Foudi, Liliane Louedec, Thierry Cachina et Charles Brink, « Selective cyclooxygenase-2 inhibition directly increases human vascular reactivity to norepinephrine during acute inflammation », Cardiovascular Research, vol. 81, n^o 2,‎ 1^er février 2009, p. 269–277 (ISSN 1755-3245, PMID 18952694, DOI 10.1093/cvr/cvn287, lire en ligne, consulté le 11 février 2017)

« Molecular Mechanisms of Drug Actions: From Receptors to Effectors - Pediatric Critical Care (Fourth Edition) - Chapter 117 », sur www.sciencedirect.com (consulté le 2 juin 2018) : « Arachidonic acid is a component of membrane phospholipids released either in a one-step process, after phospholipase A2 (PLA2) action, or a two-step process, after phospholipase C and DAG lipase actions. Arachidonic acid is then metabolized by cyclooxygenase (COX) and 5-lipoxygenase, resulting in the synthesis of prostaglandins and leukotrienes, respectively. These intracellular messengers play an important role in the regulation of signal transduction implicated in pain and inflammatory responses. »